Majamil (Diclofenac Sodium)

Diclofenac sodium blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, the drug diminishes the signals that cause pain, fever, and swelling, thereby providing analgesic and anti‑inflammatory effects at the site of tissue injury.

The appropriate dose of Majamil is determined by the prescribing healthcare professional based on the individual’s medical condition, severity of symptoms, age, renal and hepatic function, and other concurrent medications. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety of diclofenac sodium in pregnancy and lactation has not been definitively established. It is generally advised to avoid NSAIDs, including diclofenac, during the third trimester because of potential fetal cardiovascular effects. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Majamil. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details, and any necessary import documentation.

Majamil (diclofenac sodium) offers potent anti‑inflammatory and analgesic activity comparable to ibuprofen or naproxen, but it often provides longer‑lasting pain control with a once‑ or twice‑daily dosing schedule. Its gastrointestinal risk profile is similar to other non‑selective NSAIDs, so gastro‑protective strategies may be needed for high‑risk patients.

Majamil should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Majamil is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce gastrointestinal discomfort. The tablet should be swallowed whole and not split, crushed, or chewed unless specifically instructed by a healthcare professional.

The most serious risks include gastrointestinal ulceration or bleeding, severe liver injury, acute kidney damage, and cardiovascular events such as heart attack or stroke. Patients should be vigilant for signs of abdominal pain, black stools, jaundice, sudden swelling, or chest discomfort and seek medical attention promptly if they occur.

Majamil is contraindicated in individuals with known hypersensitivity to diclofenac or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, severe heart failure, and patients who have had a recent coronary artery bypass graft. It should also be avoided in patients with severe renal or hepatic impairment unless specifically directed by a physician.